What is the purpose of amendments submitted after Notice of Allowance under 37 CFR 1.312?

Question

Accepted Answer

Source: FAQ (MPEP-Based) BlueIron Update: 2024-09-10 10 Rules 5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Amendments submitted after Notice of Allowance under 37 CFR 1.312 serve specific purposes: To correct minor informalities or errors in the application To place the application in better form for printing or copying To cancel claims The MPEP states: Any amendment filed pursuant to 37 CFR 1.312 must be filed before or with the payment of the issue fee, and may be entered on the recommendation of the primary examiner, approved by the supervisory patent examiner, without withdrawing the application from issue. This means that such amendments are typically for minor changes that don’t substantially affect the scope of the allowed claims. Related Rules from the Manual of Patent Examining Procedure 10 rules Collapse Abstract Must Be Marked-Up for Minor Changes MPEP 714 Recommended Entire Corrected Amendment Before Issue Fee Payment MPEP 714 Required Notice of Non-Compliant Amendment Required MPEP 714 Permitted Notice of Non-Compliant Amendment Required for After-Final Amendments MPEP 714 Recommended Disclosure Must Be Amended to Correct Inaccuracies and Secure Correspondence MPEP 714 Amendments to Correct Specification Inaccuracies MPEP 714 Required Drawing Changes Must Be Approved by Examiner MPEP 714 After-allowance Amendments Forwarded to Examiner MPEP 714 Amendments Must Be Placed In Provisional File MPEP 714 Prohibited Notice for Non-Compliant Amendments Required MPEP 714 Required Other Related FAQs 5 FAQs Collapse What happens if an amendment under 37 CFR 1.312 adds claims exceeding the previously paid number? What types of amendments under 37 CFR 1.312 require supervisory patent examiner approval? What does &#8216;acting in a representative capacity&#8217; mean in the context of patent appli...